社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
乌龙制药(URGN)
盘后
12.06
0.03
+0.25%
19:59 EDT
12.03
+0.95
+8.57%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
小谷AI洞察
·
2024-06-14
$乌龙制药(URGN)$
这架势，今天要翻倍啊。差点卖了。
$乌龙制药(URGN)$ 这架势，今天要翻倍啊。差点卖了。
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小谷AI洞察
·
2024-06-14
$乌龙制药(URGN)$
今晚能上20吗
$乌龙制药(URGN)$ 今晚能上20吗
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
牛唐
·
2024-05-14
医药板块速评（2024.05.13）
1、
$乌龙制药(URGN)$
业绩缓慢，但数据在即，是否有配置机会？ 2、AI医药领域，哪些公司值得关注？ 3、
$Nu Holdings Ltd.(NU)$
、
$Sea Ltd(SE)$
、
$高通(QCOM)$
、$拼多多(PDD)、
$SoundHound AI Inc(SOUN)$
、$医疗不动产信托(MPW)、期权大量成交，后续走势如何看？
医药板块速评（2024.05.13）
回复
评论
点赞
1
编组 21备份 2
分享
举报
牛唐
·
2024-03-25
医药板块速评（2024.03.22）
1、四月有哪些值得关注的生物医药催化剂？ 2、
$乌龙制药(URGN)$
数据延迟，是否有抄底机会？ 3、罗氏药物数据不佳，
$Argenx SE(ARGX)$
是否有躺赢机会？
$SPDR S&P Biotech ETF(XBI)$
$诺和诺德(NVO)$
$礼来(LLY)$
医药板块速评（2024.03.22）
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
乌龙制药
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.urogen.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
乌龙制药有限公司于2004年4月以以色列国法律成立，名称为TheraCoat Ltd.，2015年9月，该公司更名为乌龙制药有限公司。该公司是一家临床阶段的生物制药公司，专注于开发旨在改变泌尿系统病理学护理标准的新型疗法。
06-13 12:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
06-10
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
05-12
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-12
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-01
[修订]年度报告
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
03-10
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03-10
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-20
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-14
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-11-18
超过5%披露
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024-11-14
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-11-14
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-11-14
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-11-14
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-11-14
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
分时
5日
日
周
月
数据加载中...
最高
14.29
今开
11.96
量比
1.89
最低
11.51
昨收
11.08
换手率
53.61%
热议股票
{"pagemeta":{"title":"乌龙制药(URGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乌龙制药(URGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乌龙制药,URGN,乌龙制药股票,乌龙制药股票老虎,乌龙制药股票老虎国际,乌龙制药行情,乌龙制药股票行情,乌龙制药股价,乌龙制药股市,乌龙制药股票价格,乌龙制药股票交易,乌龙制药股票购买,乌龙制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乌龙制药(URGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乌龙制药(URGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"URGN","data":{"stockData":{"symbol":"URGN","market":"US","secType":"STK","nameCN":"乌龙制药","latestPrice":12.03,"timestamp":1749844800000,"preClose":11.08,"halted":0,"volume":19687132,"hourTrading":{"tag":"盘后","latestPrice":12.0599,"preClose":12.03,"latestTime":"19:59 EDT","volume":644101,"amount":7744336.6913,"timestamp":1749859191651},"delay":0,"floatShares":36720545,"shares":46107451,"eps":-3.044616,"marketStatus":"休市中","change":0.95,"latestTime":"06-13 16:00:00 EDT","open":11.955,"high":14.2884,"low":11.51,"amount":249651083.731364,"amplitude":0.250758,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.044616,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NASDAQ","adjPreClose":11.08,"preHourTrading":{"tag":"盘前","latestPrice":11.97,"preClose":11.08,"latestTime":"09:29 EDT","volume":508038,"amount":5968430.424,"timestamp":1749821399045},"postHourTrading":{"tag":"盘后","latestPrice":12.0599,"preClose":12.03,"latestTime":"19:59 EDT","volume":644101,"amount":7744336.6913,"timestamp":1749859191651},"volumeRatio":1.888397507126622,"impliedVol":1.2073,"impliedVolPercentile":0.78},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.316812353331488","cardData":[{"tweetId":"316812353331488","author":{"authorId":"4138621111675080","idStr":"4138621111675080","name":"小谷AI洞察","avatar":"https://static.tigerbbs.com/ed34002d87b2f93e10d511702e995ab8","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":23,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/URGN\">$乌龙制药(URGN)$ </a> 这架势，今天要翻倍啊。差点卖了。","plainDigest":"$乌龙制药(URGN)$ 这架势，今天要翻倍啊。差点卖了。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1718365163967,"gmtModify":1718365165336,"symbols":["URGN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":696,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/316812353331488","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":45,"displayRows":2,"foldSize":0,"authorId":"4138621111675080"}]},{"cardType":"TWEET","cardId":"TWEET.316778354847824","cardData":[{"tweetId":"316778354847824","author":{"authorId":"4138621111675080","idStr":"4138621111675080","name":"小谷AI洞察","avatar":"https://static.tigerbbs.com/ed34002d87b2f93e10d511702e995ab8","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":23,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/URGN\">$乌龙制药(URGN)$ </a> 今晚能上20吗","plainDigest":"$乌龙制药(URGN)$ 今晚能上20吗","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1718356861827,"gmtModify":1718356863278,"symbols":["URGN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":466,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/316778354847824","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":28,"displayRows":2,"foldSize":0,"authorId":"4138621111675080"}]},{"cardType":"TWEET","cardId":"TWEET.305805310607392","cardData":[{"tweetId":"305805310607392","author":{"authorId":"3452938437060827","idStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.05","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":6497,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"医药板块速评（2024.05.13）","digest":"1、 <a href=\"https://laohu8.com/S/URGN\">$乌龙制药(URGN)$</a> 业绩缓慢，但数据在即，是否有配置机会？ 2、AI医药领域，哪些公司值得关注？ 3、 <a href=\"https://laohu8.com/S/NU\">$Nu Holdings Ltd.(NU)$</a> 、 <a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a> 、 <a href=\"https://laohu8.com/S/QCOM\">$高通(QCOM)$</a> 、$拼多多(PDD)、 <a href=\"https://laohu8.com/S/SOUN\">$SoundHound AI Inc(SOUN)$</a> 、$医疗不动产信托(MPW)、期权大量成交，后续走势如何看？","plainDigest":"1、 $乌龙制药(URGN)$ 业绩缓慢，但数据在即，是否有配置机会？ 2、AI医药领域，哪些公司值得关注？ 3、 $Nu Holdings Ltd.(NU)$ 、 $Sea Ltd(SE)$ 、 $高通(QCOM)$ 、$拼多多(PDD)、 $SoundHound AI Inc(SOUN)$ 、$医疗不动产信托(MPW)、期权大量成交，后续走势如何看？","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1715694070544,"gmtModify":1715694074191,"symbols":["SE","SOUN","QCOM","URGN","NU"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1479,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/305805310607392","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":218,"displayRows":2,"foldSize":0,"authorId":"3452938437060827"}]},{"cardType":"TWEET","cardId":"TWEET.288163890372608","cardData":[{"tweetId":"288163890372608","author":{"authorId":"3452938437060827","idStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.05","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":6497,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"医药板块速评（2024.03.22）","digest":"1、四月有哪些值得关注的生物医药催化剂？ 2、 <a href=\"https://laohu8.com/S/URGN\">$乌龙制药(URGN)$</a> 数据延迟，是否有抄底机会？ 3、罗氏药物数据不佳， <a href=\"https://laohu8.com/S/ARGX\">$Argenx SE(ARGX)$</a> 是否有躺赢机会？ <a href=\"https://laohu8.com/S/XBI\">$SPDR S&P Biotech ETF(XBI)$</a> <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> <a href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$</a>","plainDigest":"1、四月有哪些值得关注的生物医药催化剂？ 2、 $乌龙制药(URGN)$ 数据延迟，是否有抄底机会？ 3、罗氏药物数据不佳， $Argenx SE(ARGX)$ 是否有躺赢机会？ $SPDR S&P Biotech ETF(XBI)$ $诺和诺德(NVO)$ $礼来(LLY)$","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1711378177178,"gmtModify":1711378179186,"symbols":["LLY","URGN","NVO","ARGX","XBI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1780,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/288163890372608","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":179,"displayRows":2,"foldSize":0,"authorId":"3452938437060827"}]}],"size":4,"extra":{"requestId":"990f8f4ec8794bee9a067161526a492c","feedVerCode":"2"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"19770264","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525140339-URGN","pdf_url":"","pub_time":1749787200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"URGN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525140339/0001193125-25-140339-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525140339/d98388d8k.htm","primary":true,"translateUrl":"","linkName":"d98388d8k.htm","type":"8-K","id":"NTFILE4EM4RpnSRD6TGbK6","market":"us","size":26754}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-13 12:00","pubTimestamp":1749787200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events","summary_zh":"项目8.01：其他事项","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19756517","market":"us","labels":[],"media":"sec.gov","original_id":"AN197640825000193-URGN","pdf_url":"","pub_time":1749528000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"URGN","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000197640825000193/0001976408-25-000193-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000197640825000193/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8h91H6dFBKrWCME2","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-06-10 12:00","pubTimestamp":1749528000,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19629325","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925015956-URGN","pdf_url":"","pub_time":1747022400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"URGN","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015956/0001437749-25-015956-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015956/urgn20250331_10q.htm","primary":true,"translateUrl":"","linkName":"urgn20250331_10q.htm","type":"10-Q","id":"NTFILEG41Wqt6kapDUv7KW","market":"us","size":1741344},{"description":"EXHIBIT 10.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015956/ex_810872.htm","primary":false,"translateUrl":"","linkName":"ex_810872.htm","type":"EX-10.1","id":"NTFILEABYYCuZJT3bGWbmx","market":"us","size":438805},{"description":"EXHIBIT 31.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015956/ex_771051.htm","primary":false,"translateUrl":"","linkName":"ex_771051.htm","type":"EX-31.1","id":"NTFILEeMyDwAGMBUbi2tkY","market":"us","size":17000},{"description":"EXHIBIT 31.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015956/ex_771052.htm","primary":false,"translateUrl":"","linkName":"ex_771052.htm","type":"EX-31.2","id":"NTFILE6nNzC4XVjnidrWXg","market":"us","size":16995},{"description":"EXHIBIT 32.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015956/ex_771053.htm","primary":false,"translateUrl":"","linkName":"ex_771053.htm","type":"EX-32.1","id":"NTFILEH2ntGYCXQid9ZEyk","market":"us","size":6486},{"description":"EXHIBIT 32.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015956/ex_771054.htm","primary":false,"translateUrl":"","linkName":"ex_771054.htm","type":"EX-32.2","id":"NTFILE25hMDC2uE711tpvs","market":"us","size":6481}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-05-12 12:00","pubTimestamp":1747022400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19629251","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925015955-URGN","pdf_url":"","pub_time":1747022400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"URGN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015955/0001437749-25-015955-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015955/ex_815371.htm","primary":true,"translateUrl":"","linkName":"ex_815371.htm","type":"EX-99.1","id":"NTFILEFfc1yUsi2Y5EmUp2","market":"us","size":68931},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925015955/urgn20250428_8k.htm","primary":false,"translateUrl":"","linkName":"urgn20250428_8k.htm","type":"8-K","id":"NTFILEGHWZWAa4nCK7a69w","market":"us","size":30120}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-12 12:00","pubTimestamp":1747022400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19589101","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925013839-URGN","pdf_url":"","pub_time":1746043234000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","symbol":"URGN","title":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","titleType":"[修订]年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1668243/0001437749-25-013839-index.html","us_notice_code":"Form 10-K/A","us_title_en":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925013839/urgn20241231_10ka.htm","primary":true,"translateUrl":"","linkName":"urgn20241231_10ka.htm","type":"10-K/A","id":"NTFILE3HtdjaAniNvTQQEJ","market":"us","size":486772},{"description":"EXHIBIT 31.3","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925013839/ex_806545.htm","primary":false,"translateUrl":"","linkName":"ex_806545.htm","type":"EX-31.3","id":"NTFILE57vsh562DAeNmvmS","market":"us","size":5021},{"description":"EXHIBIT 31.4","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925013839/ex_806546.htm","primary":false,"translateUrl":"","linkName":"ex_806546.htm","type":"EX-31.4","id":"NTFILECJtU1keYdPFnbima","market":"us","size":4923},{"description":"null","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925013839/ceocompensation.jpg","primary":false,"translateUrl":"","linkName":"ceocompensation.jpg","type":"GRAPHIC","id":"NTFILED1pnSGU2E9M2YLzJ","market":"us","size":42768}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[修订]年度报告","pubTime":"2025-05-01 04:00","pubTimestamp":1746043234,"title_zh":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19222113","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925006842-URGN","pdf_url":"","pub_time":1741579200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"URGN","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/0001437749-25-006842-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/urgn20241231_10k.htm","primary":true,"translateUrl":"","linkName":"urgn20241231_10k.htm","type":"10-K","id":"NTFILEmw2efAtRurnicXJ5","market":"us","size":2272606},{"description":"EXHIBIT 4.2","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/ex_786027.htm","primary":false,"translateUrl":"","linkName":"ex_786027.htm","type":"EX-4.2","id":"NTFILEHwsAWhjjUbPgMkjF","market":"us","size":57904},{"description":"UROGEN PHARMA LTD. INSIDER TRADING POLICY","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/ex_786013.htm","primary":false,"translateUrl":"","linkName":"ex_786013.htm","type":"EX-19.1","id":"NTFILE4jitDCgXMHFe1PxH","market":"us","size":37177},{"description":"EXHIBIT 23.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/ex_727428.htm","primary":false,"translateUrl":"","linkName":"ex_727428.htm","type":"EX-23.1","id":"NTFILE2WUjEDNjiteSBvMg","market":"us","size":2304},{"description":"EXHIBIT 31.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/ex_727429.htm","primary":false,"translateUrl":"","linkName":"ex_727429.htm","type":"EX-31.1","id":"NTFILE65HiugnQyNo7Vddp","market":"us","size":13987},{"description":"EXHIBIT 31.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/ex_727430.htm","primary":false,"translateUrl":"","linkName":"ex_727430.htm","type":"EX-31.2","id":"NTFILEFUiQonEdcWdFHzNk","market":"us","size":13972},{"description":"EXHIBIT 32.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/ex_727431.htm","primary":false,"translateUrl":"","linkName":"ex_727431.htm","type":"EX-32.1","id":"NTFILE9GmS8tAXS4JuauU4","market":"us","size":7087},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006842/yepieline03052025.jpg","primary":false,"translateUrl":"","linkName":"yepieline03052025.jpg","type":"GRAPHIC","id":"NTFILEEr6DvYVKvtQhspcU","market":"us","size":80441}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-10 12:00","pubTimestamp":1741579200,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19220688","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925006757-URGN","pdf_url":"","pub_time":1741579200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"URGN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006757/0001437749-25-006757-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE DATED MARCH 10, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006757/ex_785682.htm","primary":true,"translateUrl":"","linkName":"ex_785682.htm","type":"EX-99.1","id":"NTFILECFzHuwqRduUsjau7","market":"us","size":80669},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925006757/urgn20250304_8k.htm","primary":false,"translateUrl":"","linkName":"urgn20250304_8k.htm","type":"8-K","id":"NTFILEAYyBiVDXi6Q58Qbj","market":"us","size":31133}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-03-10 12:00","pubTimestamp":1741579200,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19127907","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525030143-URGN","pdf_url":"","pub_time":1740027600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"URGN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525030143/0001193125-25-030143-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525030143/d897858d8k.htm","primary":true,"translateUrl":"","linkName":"d897858d8k.htm","type":"8-K","id":"NTFILEAbYBMfjuDBNn9CvC","market":"us","size":25600}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-02-20 13:00","pubTimestamp":1740027600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记出售股本证券","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19041065","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525005649-URGN","pdf_url":"","pub_time":1736830800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"URGN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/0001193125-25-005649-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/d903812dex991.htm","primary":true,"translateUrl":"","linkName":"d903812dex991.htm","type":"EX-99.1","id":"NTFILE7ZARz3BqaaQScBsw","market":"us","size":47405},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/d903812d8k.htm","primary":false,"translateUrl":"","linkName":"d903812d8k.htm","type":"8-K","id":"NTFILE6YaEWXEQbpm62Gfs","market":"us","size":25285},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p10g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p10g1.jpg","type":"GRAPHIC","id":"NTFILE6ad8ofA1fJwNbuSB","market":"us","size":358206},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p11g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p11g1.jpg","type":"GRAPHIC","id":"NTFILEFE75XytoBYL6bc6X","market":"us","size":352298},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p12g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p12g1.jpg","type":"GRAPHIC","id":"NTFILE8qSgpH3UfwME8QFf","market":"us","size":200541},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p13g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p13g1.jpg","type":"GRAPHIC","id":"NTFILEFcik9GMRZ1Jvhifo","market":"us","size":350708},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p14g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p14g1.jpg","type":"GRAPHIC","id":"NTFILE5NrXwamiv3JFi9U4","market":"us","size":335847},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p15g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p15g1.jpg","type":"GRAPHIC","id":"NTFILEGRs8mN531Az9Btza","market":"us","size":300317},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p16g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p16g1.jpg","type":"GRAPHIC","id":"NTFILE4G1B1vwV41SSyUYh","market":"us","size":295834},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p17g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p17g1.jpg","type":"GRAPHIC","id":"NTFILEE1rhxArW4Nu34mvh","market":"us","size":218698},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p18g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p18g1.jpg","type":"GRAPHIC","id":"NTFILE7BSayPkn6GKDiZGH","market":"us","size":287859},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p19g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p19g1.jpg","type":"GRAPHIC","id":"NTFILE8vnwYykB8XVCoSWU","market":"us","size":297293},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p1g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p1g1.jpg","type":"GRAPHIC","id":"NTFILEJ3rKSn5fpZ5c1R3T","market":"us","size":365671},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p20g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p20g1.jpg","type":"GRAPHIC","id":"NTFILE2P7ynyypumB6ib5a","market":"us","size":269143},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p21g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p21g1.jpg","type":"GRAPHIC","id":"NTFILE9DBMQDyanLqAJpci","market":"us","size":252531},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p22g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p22g1.jpg","type":"GRAPHIC","id":"NTFILE5xTjF6pcF2XgUD8C","market":"us","size":215076},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p23g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p23g1.jpg","type":"GRAPHIC","id":"NTFILE41JjNGANkSQhmgBk","market":"us","size":204761},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p24g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p24g1.jpg","type":"GRAPHIC","id":"NTFILE5QmChgTupUBTqDpz","market":"us","size":393036},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p25g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p25g1.jpg","type":"GRAPHIC","id":"NTFILED83n1KPSoppzc4LD","market":"us","size":383726},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p26g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p26g1.jpg","type":"GRAPHIC","id":"NTFILE2g9Ki3Fuax8Ya7Mz","market":"us","size":221178},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p27g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p27g1.jpg","type":"GRAPHIC","id":"NTFILECU7EqVNx6p5maCa1","market":"us","size":230432},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p28g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p28g1.jpg","type":"GRAPHIC","id":"NTFILEF4hYCJXHM1aBpY67","market":"us","size":234950},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p29g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p29g1.jpg","type":"GRAPHIC","id":"NTFILE3BgKn7UKxcXScb9W","market":"us","size":163275},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p2g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p2g1.jpg","type":"GRAPHIC","id":"NTFILEAgYVTPsKVBEAKkLF","market":"us","size":634475},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p30g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p30g1.jpg","type":"GRAPHIC","id":"NTFILEAcZ23wkUgnu52k6B","market":"us","size":287772},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p31g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p31g1.jpg","type":"GRAPHIC","id":"NTFILE4CDXo6YZ5JEtZqnW","market":"us","size":255894},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p32g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p32g1.jpg","type":"GRAPHIC","id":"NTFILE9X9HwFrmB1WfK8vd","market":"us","size":394550},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p33g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p33g1.jpg","type":"GRAPHIC","id":"NTFILE2NqbMa3Ntfur9p6t","market":"us","size":251468},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p34g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p34g1.jpg","type":"GRAPHIC","id":"NTFILE8f6DHacbSBRoCM99","market":"us","size":347009},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p35g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p35g1.jpg","type":"GRAPHIC","id":"NTFILEAcq2iG4NqhqaweqZ","market":"us","size":368678},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p36g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p36g1.jpg","type":"GRAPHIC","id":"NTFILE9RHjmpgDXFoWUy79","market":"us","size":227595},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p37g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p37g1.jpg","type":"GRAPHIC","id":"NTFILECv2jdofJvwXgQsY3","market":"us","size":255833},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p38g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p38g1.jpg","type":"GRAPHIC","id":"NTFILE8E6xGxJ9nBuTAXLQ","market":"us","size":263651},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p39g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p39g1.jpg","type":"GRAPHIC","id":"NTFILEAt3q9hfqYictxsCv","market":"us","size":351157},{"description":"GRAPHIC","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p3g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p3g1.jpg","type":"GRAPHIC","id":"NTFILE8xQzRg6aNKkz2qzH","market":"us","size":305270},{"description":"GRAPHIC","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p40g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p40g1.jpg","type":"GRAPHIC","id":"NTFILECzpQvH5AF7BNjSy2","market":"us","size":235803},{"description":"GRAPHIC","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p41g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p41g1.jpg","type":"GRAPHIC","id":"NTFILE7A8rVEf8V9qbbjxk","market":"us","size":83192},{"description":"GRAPHIC","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p42g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p42g1.jpg","type":"GRAPHIC","id":"NTFILEHFrfdvF8AePfhHWi","market":"us","size":248221},{"description":"GRAPHIC","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p43g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p43g1.jpg","type":"GRAPHIC","id":"NTFILE6cKniZVLcbnscNon","market":"us","size":295683},{"description":"GRAPHIC","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p44g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p44g1.jpg","type":"GRAPHIC","id":"NTFILEBCLcT9wGLQM364TG","market":"us","size":359679},{"description":"GRAPHIC","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p4g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p4g1.jpg","type":"GRAPHIC","id":"NTFILEC6xWApf5A1cmYSLG","market":"us","size":266775},{"description":"GRAPHIC","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p5g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p5g1.jpg","type":"GRAPHIC","id":"NTFILE193tKRsMjZjz7fXy","market":"us","size":304638},{"description":"GRAPHIC","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p6g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p6g1.jpg","type":"GRAPHIC","id":"NTFILEGCY1iDqizTZRQV3Z","market":"us","size":358900},{"description":"GRAPHIC","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p7g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p7g1.jpg","type":"GRAPHIC","id":"NTFILE7Nm5qtR3Z55fYLaT","market":"us","size":352922},{"description":"GRAPHIC","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p8g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p8g1.jpg","type":"GRAPHIC","id":"NTFILEDQdtWV3Q5bT6Hoxj","market":"us","size":289271},{"description":"GRAPHIC","seq":49,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000119312525005649/g903812ex99_1p9g1.jpg","primary":false,"translateUrl":"","linkName":"g903812ex99_1p9g1.jpg","type":"GRAPHIC","id":"NTFILE9oLw9Pn6N23j7Xdw","market":"us","size":290006}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-01-14 13:00","pubTimestamp":1736830800,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18846319","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024099322-URGN","pdf_url":"","pub_time":1731906000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","symbol":"URGN","title":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000121390024099322/0001213900-24-099322-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1668243/000121390024099322/ea0221303-13da1pontifax_uro.htm","primary":true,"translateUrl":"","linkName":"ea0221303-13da1pontifax_uro.htm","type":"SC 13D/A","id":"NTFILE7Wc5z6SHVgZ6K22u","market":"us","size":88934}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-18 13:00","pubTimestamp":1731906000,"title_zh":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18836985","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266424006639-URGN","pdf_url":"","pub_time":1731560400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"URGN","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000090266424006639/0000902664-24-006639-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UROGEN PHARMA LTD.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1603466/000090266424006639/p24-3150sc13ga.htm","primary":true,"translateUrl":"","linkName":"p24-3150sc13ga.htm","type":"SC 13G/A","id":"NTFILEAAn3skjGYTvVSjMX","market":"us","size":63968}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-14 13:00","pubTimestamp":1731560400,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18836394","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924119305-URGN","pdf_url":"","pub_time":1731560400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"URGN","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000110465924119305/0001104659-24-119305-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1346824/000110465924119305/tm2427451d29_sc13ga.htm","primary":true,"translateUrl":"","linkName":"tm2427451d29_sc13ga.htm","type":"SC 13G/A","id":"NTFILE8k7M2skFZhuofrjh","market":"us","size":81033},{"description":"EXHIBIT 1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1346824/000110465924119305/tm2427451d29_ex1.htm","primary":false,"translateUrl":"","linkName":"tm2427451d29_ex1.htm","type":"EX-99.1","id":"NTFILEFCj4nh77MQ33zsyK","market":"us","size":9454}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-14 13:00","pubTimestamp":1731560400,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18835671","market":"us","labels":[],"media":"sec.gov","original_id":"AN117266124005288-URGN","pdf_url":"","pub_time":1731560400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"URGN","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000117266124005288/0001172661-24-005288-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1281446/000117266124005288/greatpoint-urgn093024a2.htm","primary":true,"translateUrl":"","linkName":"greatpoint-urgn093024a2.htm","type":"SC 13G/A","id":"NTFILE41FjHeur5GWCTykR","market":"us","size":108670}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-14 13:00","pubTimestamp":1731560400,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18834122","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891324003701-URGN","pdf_url":"","pub_time":1731560400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"URGN","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000117891324003701/0001178913-24-003701-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1351917/000117891324003701/zk2432334.htm","primary":true,"translateUrl":"","linkName":"zk2432334.htm","type":"SC 13G/A","id":"NTFILEAL5wPFxtxbenDyfG","market":"us","size":98092}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-14 13:00","pubTimestamp":1731560400,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18832736","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266424006499-URGN","pdf_url":"","pub_time":1731560400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"URGN","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1668243/000090266424006499/0000902664-24-006499-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UROGEN PHARMA LTD.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1493215/000090266424006499/p24-3262sc13ga.htm","primary":true,"translateUrl":"","linkName":"p24-3262sc13ga.htm","type":"SC 13G/A","id":"NTFILEBRayS49wjTxktiNX","market":"us","size":64443}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-14 13:00","pubTimestamp":1731560400,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.urogen.com","stockEarnings":[{"period":"1week","weight":0.6323},{"period":"1month","weight":0.2188},{"period":"3month","weight":0.0867},{"period":"6month","weight":0.0599},{"period":"1year","weight":-0.3126},{"period":"ytd","weight":0.1296}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":0.016},{"period":"3month","weight":0.0607},{"period":"6month","weight":-0.0119},{"period":"1year","weight":0.1006},{"period":"ytd","weight":0.0186}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"乌龙制药有限公司于2004年4月以以色列国法律成立，名称为TheraCoat Ltd.，2015年9月，该公司更名为乌龙制药有限公司。该公司是一家临床阶段的生物制药公司，专注于开发旨在改变泌尿系统病理学护理标准的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.05646},{"month":2,"riseRate":0.25,"avgChangeRate":-0.051697},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010399},{"month":4,"riseRate":0.5,"avgChangeRate":0.047834},{"month":5,"riseRate":0.25,"avgChangeRate":-0.135298},{"month":6,"riseRate":0.777778,"avgChangeRate":0.284225},{"month":7,"riseRate":0.375,"avgChangeRate":0.094228},{"month":8,"riseRate":0.5,"avgChangeRate":0.031703},{"month":9,"riseRate":0.25,"avgChangeRate":-0.055568},{"month":10,"riseRate":0.5,"avgChangeRate":0.022641},{"month":11,"riseRate":0.625,"avgChangeRate":0.057405},{"month":12,"riseRate":0.375,"avgChangeRate":-0.059961}],"exchange":"NASDAQ","name":"乌龙制药","nameEN":"Urogen Pharma Ltd."},"aProfile":null}}}